Accessibility Menu
 
Mera Pharmaceuticals logo

Mera Pharmaceuticals

(OTC) MRPI

Current Price$0.00
Market Cap$500
Since IPO (1990)-100%
5 Year-100%
1 Year-99%
1 Month+0%

Mera Pharmaceuticals Financials at a Glance

Market Cap

$500

Revenue (TTM)

$302.62K

Net Income (TTM)

$187.68K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-5.45 (Low)

Price

$0.00

Volume

16,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

MRPI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Mera Pharmaceuticals

Industry

Biotechnology

Headquarters

Las Vegas, NV 89123, US

MRPI Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

19%

Return on Assets

0%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$500.00

Shares Outstanding

536.65M

Volume

16.00K

Avg. Volume

881.302

Financials (TTM)

Gross Profit

$0.00

Operating Income

$5.58

EBITDA

$0.00

Operating Cash Flow

$0.00

Capital Expenditure

$0.00

Free Cash Flow

$0.00

Cash & ST Invst.

$0.00

Total Debt

$0.00

Mera Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q4 2011YOY CHG

Revenue

$63.92K

-0.4%

Gross Profit

$61.68K

+116.6%

Gross Margin

96.51%

N/A

Market Cap

$500.00

N/A

Market Cap/Employee

$125.00

N/A

Employees

4

N/A

Net Income

$102.19K

+74.1%

EBITDA

$101.43K

+74.1%

Quarterly Fundamentals

Name
Q4 2011YOY CHG

Net Cash

$4.32K

-27.4%

Accounts Receivable

$7.85K

-11.5%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

0.00%

N/A

Return on Invested Capital

18.75%

N/A

Free Cash Flow

$72.19K

+50.2%

Operating Cash Flow

$72.19K

-1518.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ONBIONE Bio Corp.
$0.00+0.00%
DNAGDNAPrint Genomics, Inc.
$0.00+0.00%
MLPHMolecular Pharmacology (USA), Ltd.
$0.00+0.00%
NNBPNanobac Pharmaceuticals, Incorporated
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CNSPCns Pharmaceuticals
$8.48+2.67%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.21+0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.74+0.01%
IBITiShares Bitcoin Trust
$45.65+0.03%

Questions About MRPI

What is the current price of Mera Pharmaceuticals?

Mera Pharmaceuticals is trading at N/A per share.

What is the 52-week range for Mera Pharmaceuticals?

Over the past 52 weeks, Mera Pharmaceuticals has traded between N/A and $0.00.

How much debt does Mera Pharmaceuticals have?

Mera Pharmaceuticals total debt is unavailable.

How much cash does Mera Pharmaceuticals have on hand?

Mera Pharmaceuticals does not have cash on hand data available.

What is Mera Pharmaceuticals’s dividend yield?

Mera Pharmaceuticals does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.